Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 886 AL 900

Effects of the Digital App "Support, Monitoring and Reminder Technology for Mild Dementia" (SMART4MD) on People With Mild Cognitive Impairment and Their Informal Caregivers: 18-Month Multicenter Pragmatic Randomized Controlled Trial

Ghani Z, Thant PE, Saha S, Anderberg P, Aparicio MQ, Barnestein-Fonseca P, Cellek S, Cleries FM, Garolera M, Guerrero-Pertiñez G, Hayden K, Moore C, Zhang J, Berglund JS, Jarl J.

J Med Internet Res. 2026 Jul 24;28:e83123. doi: 10.2196/83123.

Standardizing care for agitation in Alzheimer's disease, results from a randomized controlled trial of an integrated care pathway versus usual care - the StaN trial

Kumar S, Burhan AM, Colman S, Chu L, Davies S, Derkach P, Elmi S, Gerretsen P, Graff-Guerrero A, Greenway K, Hussain M, Ismail Z, Kim D, Krisman L, Ma C, Moghabghab R, Mulsant BH, Pollock BG, Rej S, Rostas A, Schoer N, Streiner DL, Van Bussel L, Rajji TK; StaN Study Group.

Alzheimers Dement. 2026 Jul;22(7):e71610. doi: 10.1002/alz.71610.

Non-transgenic rodent models associated with Alzheimer's disease: applications, evaluations, and perspectives

Xing S, Ren P, Chen Z, Fu Y.

Neuroscience. 2026 Sep 28;612:335-358. doi: 10.1016/j.neuroscience.2026.07.063. Epub 2026 Jul 28.

Protecting the brain from post-stroke cognitive impairment and dementia with multimodal exercise training: study protocol for a Bayesian adaptive trial (PROTECT)

Moncion K, Rodrigues L, Bon A, Sutoski A, Sikorska K, Allison EY, Abreu J, Golchi S, Arbour N, Gauthier C, Paquette C, Rosa-Neto P, Leppert I, Rowley C, Tardiff CL, Thiel A, Al-Khazraji B, Tang A, Roig M.

BMJ Open. 2026 Jul 28;16(7):e123336. doi: 10.1136/bmjopen-2026-123336.

Effectiveness of non-pharmacological interventions for older adults with dementia: An umbrella review

Saito T, Shimizu N, Yao L.

Int J Nurs Sci. 2026 Jul;13(4):380-386. doi: 10.1016/j.ijnss.2026.06.008. Epub 2026 Jun 22.

Central sensitization syndromes as a neuropsychiatric risk state for dementia: Clinical and epidemiologic perspectives

Hackshaw KV.

CNS Spectr. 2026 Jul 29;31(1):e29. doi: 10.1017/S1092852926101114.

Association of Sleep Variables With Cognitive Performance and the Risk of Dementia in the Sleep and Dementia Consortium

Yiallourou S, Wiedner C, Yang Q, Baril AA, Misialek JR, Kline CE, Harrison S, Bernal R, Bisson A, Himali D, Chiu T, Cavuoto MG, Ancoli-Israel S, Xiao Q, Vaou EO, Weihs A, Leng Y, Gottesman RF, Beiser AS, Lopez OL, Lutsey PL, Purcell S, Redline S, Seshadri S, Stone KL, Yaffe K, Pase MP, Himali JJ.

Neurology. 2026 Aug 25;107(4):e218182. doi: 10.1212/WNL.0000000000218182. Epub 2026 Jul 29.

Validation of Plasma p-tau217 as a Biomarker of Prodromal Alzheimer's Disease

Monge-García V, Lorenzo-García S, Bernal-Soriano MC, Torrella-Esteban P, Monge-García S, Sánchez-Payá J, Monge-Argilés JA.

Rev Neurol. 2026 Jul 21;81(7):50619. doi: 10.31083/RN50619.

AI-Enabled Modeling for Alzheimer's Disease Risk Prediction and Validation

Li P, Wang Y.

Rev Neurol. 2026 Jul 21;81(7):49220. doi: 10.31083/RN49220.

Validation of the VasCog-2-WSO VCID Criteria in a Dementia-Free and Stroke-Free Community Cohort: Cardiovascular Risk and Mortality

Lin YR, Lee WJ, Lee PL, Lin CP, Wang PN, Chen LK, Chung CP.

Neurology. 2026 Aug 25;107(4):e218311. doi: 10.1212/WNL.0000000000218311. Epub 2026 Jul 30.

BACH1/HO-1 axis dysregulation links Down syndrome to Alzheimer-like neurodegeneration

Di Domenico F, Barone E, Perluigi M.

Neurochem Int. 2026 Oct;199:106232. doi: 10.1016/j.neuint.2026.106232. Epub 2026 Jul 30.

Evaluating digital cognitive tests for clinical use in Alzheimer's disease: A novel framework and scoping review

Hampel H, Nakamura Y, Bell J, Hendrix S, Derchansky M, Montezano BB, Stoeckel LE, Teipel S, Willis DR, Cummings JL, Cobb BR.

Alzheimers Dement. 2026 Aug;22(8):e71559. doi: 10.1002/alz.71559.

Neurocognitive outcomes and survival with high- vs low-intensity statins in stroke survivors: A propensity score-matched cohort (2010-2025)

Zahran A, Bdair M, Milhem F, Jallad H, Awartani A, Khaled A, Salah Q, Jamaleddin R, Thouqan L, Aldarak S.

J Stroke Cerebrovasc Dis. 2026 Sep;35(9):108721. doi: 10.1016/j.jstrokecerebrovasdis.2026.108721. Epub 2026 Aug 3.

The role of polygenic risk in Alzheimer's disease prediction for African Americans

Hutten CG, Beck T, Evans D, Rajan KB.

Alzheimers Dement. 2026 Aug;22(8):e71712. doi: 10.1002/alz.71712.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias